ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 105 filers reported holding ENDOLOGIX INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,717,000 | -53.1% | 2,398,414 | +25.0% | 0.05% | -46.2% |
| Q3 2018 | $3,664,000 | -10.8% | 1,918,340 | +127.0% | 0.09% | -35.5% |
| Q2 2017 | $4,107,000 | -25.8% | 845,016 | +10.5% | 0.14% | -29.9% |
| Q1 2017 | $5,536,000 | +20.5% | 764,688 | -4.8% | 0.20% | +7.5% |
| Q4 2016 | $4,594,000 | +217.7% | 803,096 | +610.7% | 0.19% | +196.8% |
| Q3 2016 | $1,446,000 | +23.7% | 112,995 | +20.4% | 0.06% | +21.2% |
| Q2 2016 | $1,169,000 | +72.9% | 93,860 | +16.2% | 0.05% | +57.6% |
| Q1 2016 | $676,000 | -9.0% | 80,807 | +85.8% | 0.03% | -2.9% |
| Q1 2015 | $743,000 | -48.0% | 43,500 | -46.9% | 0.03% | -52.1% |
| Q4 2013 | $1,428,000 | +32.7% | 81,903 | +22.8% | 0.07% | +22.4% |
| Q3 2013 | $1,076,000 | +39.2% | 66,693 | +14.6% | 0.06% | +34.9% |
| Q2 2013 | $773,000 | – | 58,174 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,121,447 | $5,450,000 | 2.37% |
| Essex Woodlands Management, Inc. | 1,257,468 | $11,699,000 | 2.12% |
| Redmile Group, LLC | 6,368,299 | $30,950,000 | 1.88% |
| Camber Capital Management LP | 7,500,000 | $36,450,000 | 1.78% |
| Sio Capital Management, LLC | 493,060 | $2,396,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 1,575,000 | $7,655,000 | 1.10% |
| PFM Health Sciences, LP | 5,599,466 | $27,213,000 | 0.73% |
| Elk Creek Partners, LLC | 2,087,238 | $10,144,000 | 0.66% |
| Partner Investment Management, L.P. | 99,736 | $485,000 | 0.65% |
| Brown Capital Management | 8,783,162 | $42,686,000 | 0.52% |